AccuStem Sciences, Inc. (ACUT)
OTCMKTS: ACUT · Delayed Price · USD
0.390
0.00 (0.00%)
Aug 29, 2024, 1:11 PM EDT - Market closed
AccuStem Sciences Employees
AccuStem Sciences had 3 employees as of December 31, 2023. The number of employees decreased by 1 or -25.00% compared to the previous year.
Employees
3
Change (1Y)
-1
Growth (1Y)
-25.00%
Revenue / Employee
n/a
Profits / Employee
-$581,308
Market Cap
4.43M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3 | -1 | -25.00% |
| Dec 31, 2022 | 4 | 0 | - |
| Dec 31, 2021 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
ACUT News
- 1 year ago - AccuStem Sciences, Inc. and EmeritusDX Announce Joint Product Development Agreement and Strategic Partnership - GlobeNewsWire
- 1 year ago - AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo di Oncologia (IEO) Enabling its Strategic Approach to Address Unanswered Clinical Questions in Early Stage Breast Cancer - GlobeNewsWire
- 1 year ago - Goldman Small Cap Research Publishes New Research Report on AccuStem Sciences, Inc. - Accesswire
- 1 year ago - AccuStem Sciences, Inc. Announces Collaboration Agreement with University Hospitals - GlobeNewsWire
- 1 year ago - AccuStem Announce Strategic Clinical and Operational Partnership - GlobeNewsWire
- 1 year ago - AccuStem Sciences Announces Extension of its US Patent Application for SPARE Test for Patients with Breast Cancer - GlobeNewsWire
- 1 year ago - AccuStem Sciences, Inc. Announces Chairman Purchase of Shares - GlobeNewsWire
- 1 year ago - AccuStem Sciences Announces Appointment of Sean McDonald to Board of Directors - GlobeNewsWire